Consensus on the clinical utility of digital mobility outcomes for personalized clinical decision support in parkinson's disease.

ABSTRACT:

Background

Digital mobility outcomes (DMOs) have emerged as novel biomarkers offering objective, quantitative, and examiner-independent outcome measures for clinical studies. Unfortunately, research efforts on DMOs have not yet investigated the domain of clinical utility in Parkinson's disease, i.e. providing evidence of improvements in health outcomes, diagnosis, decision-making, or prevention when compared to e.g. standard-of-care procedures. This manuscript, via a consensus building approach, aims to create a structured conceptual framework to map the knowledge generated by DMOs with clinical domains that could benefit from it.

Methods

We conducted a three-round consensus-building study with 12 experts recruited from the Mobilise-D consortium's Parkinson's Disease Working

SUBMITTER: Mejia AC 

PROVIDER: S-EPMC12447593 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature